Akèy › Lekemi selil B › Texas › Dallas
Etid klinik pou Lekemi selil B nan Dallas, TX
5 etid pou Lekemi selil B ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Ap rekriteFaz 2
- UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Ap rekriteFaz 2
- University of Texas, Southwestern, Dallas
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
Ap rekriteFaz 1
- UT Southwestern Medical Center, Dallas
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Ap rekriteFaz 1/2
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Ap rekriteEtid obsèvasyon
- Ut Southwestern, Dallas
Etid Lekemi selil B nan lòt vil
- Houston, TX7 etid
- Washington, DC5 etid
- Columbus, OH4 etid
- Portland, OR4 etid
- Philadelphia, PA3 etid
- Spokane, WA3 etid
- New York City, NY3 etid
- Boston, MA3 etid
- Clifton, NJ3 etid
- San Diego, CA3 etid
- Charlotte, NC3 etid
- Louisville, KY3 etid
Lòt etid nan Dallas
- Kansè nan tete55 etid
- Kansè Poumon ki pa ti selil52 etid
- Kansè Metastatik42 etid
- Ensifizyans kadyak42 etid
- Kansè (tout kalite)37 etid
- Kansè pwostat36 etid
- Kansè kolorektal33 etid
- Obèsite30 etid
- Kansè ovè28 etid
- Kansè vejik27 etid
- Kansè poumon27 etid
- Kansè Endomèt24 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.